Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

46 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
PORTRESS - the PORTuguese Reuma.pt registry for Sjögren'S disease.
Bandeira M, Silvério-António M, Costa RPD, Lopes AR, Santos FC, Pereira PJ, Raimundo DB, Cunha A, Oliveira CP, Duarte AC, Dias J, Santos ME, Gonçalves MJ, Moniz AC, Maduro AI, Luís M, Valido A, Oliveira M, Brites L, Tenazinha C, Vieira A, Khmelinskii N, Barcelos F, Fonseca JE, Romão VC, Force PRPT. Bandeira M, et al. Among authors: khmelinskii n. ARP Rheumatol. 2025 Jul-Sep;4(3):183-193. ARP Rheumatol. 2025. PMID: 41030030 Free article. English.
Synovial biopsy in a case of nivolumab-induced arthritis.
Pereira da Costa R, Pinho M, Patrocínio J, Torres S, Ferreira C, Fonseca JE, Khmelinskii N. Pereira da Costa R, et al. Among authors: khmelinskii n. Clin Exp Rheumatol. 2025 Sep 2. doi: 10.55563/clinexprheumatol/2z7vho. Online ahead of print. Clin Exp Rheumatol. 2025. PMID: 40892639 No abstract available.
The use of ASDAS to evaluate disease activity and response to treatment in patients with axial spondyloarthritis starting the first biological drug: Are ASAS recommendations being followed?
Santos ME, Ramiro S, van der Heijde D, Landewé R, Cruz-Machado AR, Ferreira CC, Marques-Gomes C, Soares CD, Miguel C, Albuquerque F, Martins F, Silva L, Santos H, Almeida I, Bernardes M, Khmelinskii N, Valente P, Teixeira PM, Matias SE, Fraga V, Pimentel-Santos F, Branco JC, Sepriano A. Santos ME, et al. Among authors: khmelinskii n. Semin Arthritis Rheum. 2025 Oct;74:152781. doi: 10.1016/j.semarthrit.2025.152781. Epub 2025 Jul 18. Semin Arthritis Rheum. 2025. PMID: 40712275
Vision-related quality of life in spondyloarthritis patients with acute anterior uveitis on golimumab: the GO-VISION study.
Leal I, Melo AT, Ochôa Matos C, Ferreira C, Tenazinha C, Vaz C, Dourado E, Pimentel F, Cunha Santos F, Fernandes H, Fonseca Ferreira J, Silvério-António M, Faria M, Guedes M, Cordeiro M, Santos M, Khmelinskii N, José P, Pinto P, Barão R, Dinis S, Mano S, Fonseca S, Marques-Neves C, Vieira-Sousa E, Fonseca JE. Leal I, et al. Among authors: khmelinskii n. Clin Exp Rheumatol. 2025 Jul 4. doi: 10.55563/clinexprheumatol/adr1j3. Online ahead of print. Clin Exp Rheumatol. 2025. PMID: 40658476
ERN ReCONNET-SLICC-SLEuro expert consensus on the therapeutic management of rare systemic lupus erythematosus manifestations.
Arnaud L, Ruiz-Irastorza G, Aranow C, Bernatsky S, Dall'Era M, Adelowo O, Bae SC, Beretta L, Bonfa E, Cervera R, Chasset F, Clarke AE, Costedoat-Chalumeau N, Doria A, Espinosa G, Fanouriakis A, Fredi M, Gatto M, Gladman DD, Gomez-Puerta JA, Inanç M, Ines LS, Isenberg D, Izuka S, Khmelinskii N, Legge A, Macieira C, Monticielo OA, Morand EF, Muñoz-Louis R, Padjen I, Petri M, Piga M, Pons-Estel BA, Ramirez GA, Ramsey-Goldman R, Richez C, Sciascia S, Toro-Gutierrez CE, Van Vollenhoven RF, Vital EM, Gerosa M, Touma Z, Mosca M, Tani C; European Reference Network on Rare and Complex Connective Tissue and Musculoskeletal, Diseases; Systemic Lupus Erythematosus International Collaborating Clinics group; European Lupus Society rare systemic lupus erythematosus taskforce member panel. Arnaud L, et al. Among authors: khmelinskii n. Lancet Rheumatol. 2025 Jul;7(7):e505-e518. doi: 10.1016/S2665-9913(25)00063-3. Epub 2025 May 23. Lancet Rheumatol. 2025. PMID: 40418946 Review.
A Phase 3 Trial of Upadacitinib for Giant-Cell Arteritis.
Blockmans D, Penn SK, Setty AR, Schmidt WA, Rubbert-Roth A, Hauge EM, Keen HI, Ishii T, Khalidi N, Dejaco C, Cid MC, Hellmich B, Liu M, Zhao W, Lagunes I, Romero AB, Wung PK, Merkel PA; SELECT-GCA Study Group. Blockmans D, et al. N Engl J Med. 2025 May 29;392(20):2013-2024. doi: 10.1056/NEJMoa2413449. Epub 2025 Apr 2. N Engl J Med. 2025. PMID: 40174237 Clinical Trial.
The giant cell arteritis (GCA) ultrasound score (OGUS) at diagnosis and after initial treatment predicts future relapses in GCA patients: results of a multicentre prospective study.
Monti S, Ponte C, Schäfer VS, Rozza D, Scirè C, Franchi G, Milanesi A, Khmelinskii N, Petzinna SM, Carrara G, Di Nicola C, Fonseca JE, Montecucco C, Schmidt WA, Dejaco C, Luqmani RA. Monti S, et al. Among authors: khmelinskii n. Ann Rheum Dis. 2025 May;84(5):823-832. doi: 10.1016/j.ard.2025.01.018. Epub 2025 Feb 6. Ann Rheum Dis. 2025. PMID: 39919971
46 results